Spots Global Cancer Trial Database for vaginal cancer
Every month we try and update this database with for vaginal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | NCT02653118 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | V503 GARDASIL | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
MR-HIFU for Recurrent Gynaecological Cancer | NCT02714621 | Cervical Cancer Endometrial Can... Uterine Cancer Ovarian Cancer Vaginal Cancer Vulvar Cancer | Magnetic Resona... | 18 Years - | Institute of Cancer Research, United Kingdom | |
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
A Survivorship Care Plan for Gynaecological Cancer Patients | NCT01582906 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | NCT02096783 | Anxiety Disorde... Cervical Cancer Endometrial Can... Female Reproduc... Gestational Tro... Ovarian Epithel... Ovarian Germ Ce... Sexual Dysfunct... Uterine Sarcoma Vaginal Cancer Vulvar Cancer | informational i... counseling inte... questionnaire a... | 18 Years - | University of Wisconsin, Madison | |
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | NCT02280811 | Vaginal Cancer Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal C... | Fludarabine Cyclophosphamid... E6 TCR Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function | NCT00588081 | Vaginal Cancer | QOL | - | Memorial Sloan Kettering Cancer Center | |
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT05372016 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | Experimental: E... Active Comparat... | 16 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | NCT00943722 | Cervical Cancer... Vulvar Cancer Vaginal Cancer Genital Lesions PAP Test Abnorm... HPV Infections | V503 | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Pelvic Fractures and Radiation Therapy for Cervical Cancer | NCT00800644 | Cervical Cancer Endometrial Can... Vaginal Cancer | CT or MRI + Blo... | - | M.D. Anderson Cancer Center | |
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
Effectiveness of an Individualized Symptom Education Program (ISEP) | NCT00275353 | Uterine Cancer Cervical Cancer Vaginal Cancer Vulvar Cancer | Individualized ... | 18 Years - | University of Toronto | |
Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
Questionnaire Study for Gynecological Cancer Survivors | NCT00391664 | Endometrial Neo... Ovarian Neoplas... Uterine Cervica... Vulvar Neoplasm... Vaginal Neoplas... Genital Neoplas... | Psychosocial | 20 Years - 75 Years | Walter Reed Army Medical Center | |
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT03676101 | Cervical Cancer... Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcin... Mild Dysplasia ... Moderate Dyspla... Vin III VaIN1 VaIN2 VaIN3 Genital Wart | 9-valent HPV Re... Placebo | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer | NCT06292689 | Vulvar and Vagi... | Cardunolizumab | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation | NCT04626466 | Prostate Carcin... Rectum Carcinom... Anal Canal Carc... Endometrium Car... Cervix Carcinom... Radiotherapy Vaginal Cancer | Biological inve... | 18 Years - 79 Years | Institut de cancérologie Strasbourg Europe | |
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study | NCT06284343 | Cancer-associat... Venous Thromboe... Gynecologic Can... Ovarian Cancer Cervix Cancer Endometrial Can... Vaginal Cancer | Anticoagulant | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers | NCT02003430 | Non-ovarian Gyn... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China | NCT05662020 | Human Papilloma... | Recombinant Non... GARDASIL® 9 | 9 Years - 26 Years | Beijing Health Guard Biotechnology, Inc | |
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy | NCT02058550 | Cervical Cancer Endometrial Can... Radiation Toxic... Vaginal Cancer | survey administ... computer-assist... telephone-based... | 18 Years - | Stanford University | |
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | NCT00520598 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: V50... Comparator: V50... Comparator: V50... Comparator: V50... Comparator: Qua... Comparator: Pla... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
Internet-based System for Cancer Patients to Self-report Toxicity | NCT00578006 | Cervical Cancer Lung Cancer Prostate Cancer Vaginal Cancer Ovarian Cancer Breast Cancer Bladder Cancer | Questioners STAR website | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | NCT00381888 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Thromboembolism Vaginal Cancer Vulvar Cancer | fondaparinux so... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer | NCT02458001 | Cervical Cancer Ovarian Cancer Uterine Cancer Vaginal Cancer Vulval Cancer Psychosexual Dy... | SAFFRON stepped... | 18 Years - | University College, London | |
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002) | NCT00943722 | Cervical Cancer... Vulvar Cancer Vaginal Cancer Genital Lesions PAP Test Abnorm... HPV Infections | V503 | 9 Years - 26 Years | Merck Sharp & Dohme LLC | |
Evaluation of Robot-Assisted Surgery in Gynecologic Oncology | NCT00671827 | Gynecologic Can... | Questionnaire | - | M.D. Anderson Cancer Center | |
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | NCT00118300 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer | capecitabine brachytherapy radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies | NCT05979610 | Gynecologic Neo... Brachytherapy Therapeutic Tou... Endometrial Can... Cervical Cancer Vaginal Cancer Vulvar Cancer | Reiki therapy | 18 Years - | University of Utah | |
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | NCT04708470 | Oropharyngeal C... Neck Cancer Human Papilloma... HPV Anal Cancer Cervical Cancer Penile Cancer Vulvar Cancer Vaginal Cancer Colon Cancer | Bintrafusp Alfa NHS-IL12 Entinostat | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | NCT00944944 | Ovarian Cancer Uterine Cancer Vaginal Cancer Lymphedema | limb volume mea... GCLQ lymphedema... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | NCT00905658 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | therapeutic nut... standard follow... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors | NCT05949632 | Advanced Solid ... | INCB099280 axitinib | 18 Years - | Incyte Corporation | |
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer | NCT01097239 | Rectal Cancer Ovarian Cancer Endometrial Can... Vaginal Cancer Cervical Cancer | Sonablate 500 (... | 18 Years - | Imperial College London | |
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer | NCT00005941 | Cervical Cancer Vaginal Cancer | therapeutic all... cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | - 64 Years | Fred Hutchinson Cancer Center | |
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | NCT03346915 | Human Papilloma... Cervical Cancer Human Papilloma... Oropharyngeal C... Vaginal Cancer Vulvar Cancer Anal Cancer Penile Cancer | WoW and BNI | 9 Years - 65 Years | Boston Medical Center | |
Validation of a Nutrition Screening Tool | NCT01851928 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | 18 Years - 60 Years | Royal Marsden NHS Foundation Trust | ||
Image-Guided Gynecologic Brachytherapy | NCT02993900 | Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer Bladder Cancer | Image-Guided Br... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT04425291 | Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 4-valent HPV Va... 9-valent HPV Va... GARDASIL® | 20 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | NCT00033605 | Cervical Cancer Colorectal Canc... Diarrhea Endometrial Can... Fallopian Tube ... Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... Vaginal Cancer Vulvar Cancer | octreotide acet... placebo radiation | 18 Years - | Alliance for Clinical Trials in Oncology | |
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine | NCT05371353 | HPV Infections Cervical Cancer... Vaginal Cancer Genital Wart CIN1 CIN2 CIN3 | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | ||
Pelvic Fractures and Radiation Therapy for Cervical Cancer | NCT00800644 | Cervical Cancer Endometrial Can... Vaginal Cancer | CT or MRI + Blo... | - | M.D. Anderson Cancer Center | |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies | NCT05979610 | Gynecologic Neo... Brachytherapy Therapeutic Tou... Endometrial Can... Cervical Cancer Vaginal Cancer Vulvar Cancer | Reiki therapy | 18 Years - | University of Utah | |
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | NCT04895020 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 9-valent HPV va... | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer | NCT01097239 | Rectal Cancer Ovarian Cancer Endometrial Can... Vaginal Cancer Cervical Cancer | Sonablate 500 (... | 18 Years - | Imperial College London | |
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy | NCT02058550 | Cervical Cancer Endometrial Can... Radiation Toxic... Vaginal Cancer | survey administ... computer-assist... telephone-based... | 18 Years - | Stanford University | |
Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | NCT00944944 | Ovarian Cancer Uterine Cancer Vaginal Cancer Lymphedema | limb volume mea... GCLQ lymphedema... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | NCT00545792 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer Carcinoma of th... | Avastin | 18 Years - | Dana-Farber Cancer Institute | |
Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers | NCT02003430 | Non-ovarian Gyn... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | NCT01216813 | Adenocarcinoma ... Cervical Cancer Endometrial Can... Esophageal Canc... Fallopian Tube ... Gastric Cancer Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | informational i... assessment of t... psychosocial as... | 18 Years - 120 Years | National Cancer Institute (NCI) | |
Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by Radiotherapy and Brachytherapy | NCT03956498 | Cervix Cancer Vaginal Cancer | Patients with c... | 18 Years - | Institut Claudius Regaud | |
Internet-based System for Cancer Patients to Self-report Toxicity | NCT00578006 | Cervical Cancer Lung Cancer Prostate Cancer Vaginal Cancer Ovarian Cancer Breast Cancer Bladder Cancer | Questioners STAR website | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Lymphoscintigraphy in Patients With Vaginal Cancer | NCT00528034 | Vaginal Cancer | Lymphoscintigra... | - | M.D. Anderson Cancer Center | |
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years | NCT05027776 | HPV Infections Cervical Cancer... Vaginal Cancer Genital Wart CIN1 CIN2 CIN3 | 2-doses Group a... 3-doses Group a... 3-doses Group a... | 9 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
3D Printed Custom Applicators for HDR BT (DISCO) | NCT06432478 | Gynecologic Can... Endometrial Can... Vaginal Cancer Vulva Cancer | 3D-printed cust... | 18 Years - | Royal North Shore Hospital | |
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | NCT00905658 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | therapeutic nut... standard follow... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer | NCT06292689 | Vulvar and Vagi... | Cardunolizumab | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
ChemoFx® PRO - A Post-Market Data Collection Study | NCT00669422 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... Uterine Neoplas... Endometrial Can... Vaginal Cancer Vulvar Cancer Cervical Cancer | 18 Years - | Precision Therapeutics | ||
Image-Guided Gynecologic Brachytherapy | NCT01399658 | Cervical Cancer Uterine Cancer Vaginal Cancer Carcinoma of th... | Image-guided br... 3'-Deoxy-3'-18f... | 18 Years - | Dana-Farber Cancer Institute | |
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | NCT00002562 | Cervical Cancer Vaginal Cancer | paclitaxel | - | National Cancer Institute (NCI) | |
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT03676101 | Cervical Cancer... Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN 3 AIS Invasive Carcin... Mild Dysplasia ... Moderate Dyspla... Vin III VaIN1 VaIN2 VaIN3 Genital Wart | 9-valent HPV Re... Placebo | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | NCT01585428 | Cervical Cancer Oropharyngeal C... Vaginal Cancer Anal Cancer Penile Cancer | Fludarabine Cyclophosphamid... Young TIL Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
Retrospective Study of Brachytherapy | NCT05242861 | Brachytherapy Uterine Cervica... Uterine Neoplas... Vulvar Cancer Vaginal Cancer Ovarian Neoplas... Gynecologic Neo... | Brachytherapy | 18 Years - 80 Years | Zhejiang Cancer Hospital | |
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance | NCT00581646 | Cervical Cancer Endometrial Can... Leukemia Non-Hodgkin's L... Uterine Cancer Vaginal Cancer Infertility | survey instrume... | 18 Years - 49 Years | Memorial Sloan Kettering Cancer Center | |
NYSCF Scientific Discovery Biobank | NCT06203106 | ALS Amyotrophic Lat... Alzheimer Disea... Alzheimer Disea... Alzheimer Disea... Batten Disease Corticobasal De... Dementia Frontotemporal ... Huntington Dise... Lewy Body Disea... Multiple Sclero... Multiple System... Parkinson Disea... Parkinson's Dis... Progressive Sup... INAD Diabetes Diabetes Mellit... Diabetes Mellit... Diabetes Mellit... Macular Degener... Ovarian Cancer Cervical Cancer Uterine Cancer Vaginal Cancer Vulvar Cancer PTSD Post Traumatic ... | Biological Samp... | 30 Days - | New York Stem Cell Foundation Research Institute | |
Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers | NCT00545792 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer Carcinoma of th... | Avastin | 18 Years - | Dana-Farber Cancer Institute | |
Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer | NCT06314568 | Vaginal Cancer | Radiochemothera... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | NCT02280811 | Vaginal Cancer Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal C... | Fludarabine Cyclophosphamid... E6 TCR Aldesleukin | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine | NCT05680454 | Human Papilloma... | Recombinant Non... Recombinant non... | 18 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
ASk Questions in GYnecologic Oncology (ASQ-GYO) | NCT06339827 | Ovarian Cancer Endometrial Can... Cervical Cancer Vulvar Cancer Vaginal Cancer Gestational Tro... | Administration ... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer | NCT06314568 | Vaginal Cancer | Radiochemothera... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study | NCT06284343 | Cancer-associat... Venous Thromboe... Gynecologic Can... Ovarian Cancer Cervix Cancer Endometrial Can... Vaginal Cancer | Anticoagulant | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |